两兄弟迟发性基底细胞癌的基因组特征与NBCCS三打击机制
研究对两例40岁后才出现基底细胞癌的NBCCS兄弟及其同胞进行全外显子组和RNA测序,发现9个肿瘤中8个存在同一单倍型的PTCH1杂合性缺失,该单倍型携带胚系剪接位点突变c.763-6C>A。所有肿瘤均另获体细胞PTCH1功能缺失突变,提示该胚系突变为亚效等位基因,三打击序列导致迟发肿瘤。
要点
- NBCCS患者40岁后迟发BCC需警惕亚效PTCH1胚系突变可能
- 肿瘤中PTCH1双等位基因失活需两次体细胞事件完成
- 同一家族中PTCH1突变可表现不完全外显与迟发表型
核心结论
- 两兄弟迟发性BCC由PTCH1亚效胚系突变、体细胞LOH及额外PTCH1失活突变三步遗传事件驱动。
研究设计与样本
- 对四名同胞取血,对两例NBCCS兄弟的9个BCC行全外显子组和RNA测序。
主要发现
- 9个肿瘤中8个存在同一9号染色体单倍型的PTCH1杂合性缺失,该单倍型含胚系剪接位点突变c.763-6C>A。
- 所有BCC均携带额外的体细胞PTCH1功能缺失突变,这在典型NBCCS中不常见。
- 所有BCC的肿瘤突变负荷与无关NBCCS患者BCC相似,但 damaging PTCH1突变数更高。
关键数值与推荐
- 胚系PTCH1突变NM_001083605:exon9:c.763-6C>A与疾病共分离。
- 8/9肿瘤LOH涉及同一单倍型;所有肿瘤均获额外PTCH1功能缺失突变。
临床怎么用
- 对迟发BCC且符合NBCCS特征者,应检测PTCH1胚系突变并评估其亚效性。
- 肿瘤基因测序可识别PTCH1双等位失活模式以辅助诊断。
局限性
- 仅两例患者和9个肿瘤,样本量小。
- 未提供功能实验直接验证该剪接突变的亚效效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant genetic disorder. It is commonly caused by mutations in PTCH1 and chiefly characterized by multiple basal cell carcinomas (BCCs) developing prior to the age of 30 years. In rare cases, NBCCS presents with a late onset of BCC development. OBJECTIVE: To investigate BCC tumorigenesis in two brothers, who showed characteristic features of NBCCS but developed their first BCCs only after the age of 40 years. Two other siblings did not show signs of NBCCS. RESULTS: We obtained blood samples from four siblings and nine BCCs from the two brothers with NBCCS. Whole exome sequencing and RNA sequencing revealed loss of heterozygosity (LOH) of PTCH1 in eight out of nine tumours that consistently involved the same haplotype on chromosome 9. This haplotype contained a germinal splice site mutation in PTCH1 (NM_001083605:exon9:c.763-6C>A). Analysis of germline DNA confirmed segregation of this mutation with the disease. All BCCs harboured additional somatic loss-of-function (LoF) mutations in the remaining PTCH1 allele which are not typically seen in other cases of NBCCS. This suggests a hypomorphic nature of the germinal PTCH1 mutation in this family. Furthermore, all BCCs had a similar tumour mutational burden compared to BCCs of unrelated NBCCS patients while harbouring a higher number of damaging PTCH1 mutations. CONCLUSIONS: Our data suggest that a sequence of three genetic hits leads to the late development of BCCs in two brothers with NBCCS: a hypomorphic germline mutation, followed by somatic LOH and additional mutations that complete PTCH1 inactivation. These genetic events are in line with the late occurrence of the first BCC and with the higher number of damaging PTCH1 mutations compared to usual cases of NBCCS.
引用
- Hasan Ali O, Yurchenko AA, Pavlova O, et al. Genomic profiling of late-onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndrome. J Eur Acad Dermatol Venereol. 2020. PMID: 32564428. doi:10.1111/jdv.16767
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。